Capreomycin sulfate labels and packages

Revision as of 00:27, 25 December 2013 by Chetan Lokhande (talk | contribs)
Jump to navigation Jump to search
Capreomycin Sulfate
CAPASTAT SULFATE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels and Package

CAPASTAT® SULFATE Container Label Principal Display Panel Text:[1]


1 VIAL NDC 17478-080-50

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

Rx only

File:CAPASTAT SULFATE CAPREOMYCIN INJECTION POWDER FOR SOLUTION AKORN .jpg


CAPASTAT® SULFATE Carton Label Principal Display Panel Text:

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

FOR INTRAMUSCULAR AND INTRAVENOUS INFUSION ONLY

Rx only


References

  1. "CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.